Whether reduced tumor growth in vivo was due to the absence of tumor cell IL-6 or to reduced growth substrates (e.g., amino acids, FAs, glycerol) due to reduced cachexia is a complex question under active investigation in our laboratory. The gene discussed is IL6; the disease is neoplasm.